These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1881263)
1. In vivo proton magnetic resonance imaging and localized spectroscopic analysis of polycystic kidney disease in DBA/2FG-pyc mice. Towner RA; Yamaguchi T; Philbrick DJ; Holub BJ; Janzen EG; Takahashi H Magn Reson Imaging; 1991; 9(3):429-34. PubMed ID: 1881263 [TBL] [Abstract][Full Text] [Related]
2. Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Yamaguchi T; Nagao S; Kasahara M; Takahashi H; Grantham JJ Am J Kidney Dis; 1997 Nov; 30(5):703-9. PubMed ID: 9370187 [TBL] [Abstract][Full Text] [Related]
3. Strain difference in expression of the adult-type polycystic kidney disease gene, pcy, in the mouse. Nagao S; Hibino T; Koyama Y; Marunouchi T; Konishi H; Takahashi H Jikken Dobutsu; 1991 Jan; 40(1):45-53. PubMed ID: 2007434 [TBL] [Abstract][Full Text] [Related]
4. Anemia in new congenital adult type polycystic kidney mice. Koumegawa J; Nagano N; Arai H; Wada M; Kusaka M; Takahashi H J Urol; 1991 Dec; 146(6):1645-9. PubMed ID: 1942361 [TBL] [Abstract][Full Text] [Related]
5. The effect of paclitaxel on the progression of polycystic kidney disease in rodents. Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221 [TBL] [Abstract][Full Text] [Related]
6. Renal carbonic anhydrase activity in DBA/2FG-pcy/pcy mice with inherited polycystic kidney disease. Kaneta S; Ishizuki S; Kasahara M; Nagao S; Takahashi H Exp Anim; 1999 Jul; 48(3):161-9. PubMed ID: 10480021 [TBL] [Abstract][Full Text] [Related]
7. Abnormal lipid and fatty acid compositions of kidneys from mice with polycystic kidney disease. Aukema HM; Yamaguchi T; Takahashi H; Celi B; Holub BJ Lipids; 1992 Jun; 27(6):429-35. PubMed ID: 1385849 [TBL] [Abstract][Full Text] [Related]
8. Morphologic and dynamic renal imaging with assessment of glomerular filtration rate in a pcy-mouse model using a clinical 3.0 Tesla scanner. Sadick M; Schock D; Kraenzlin B; Gretz N; Schoenberg SO; Michaely HJ Invest Radiol; 2009 Aug; 44(8):469-75. PubMed ID: 19465861 [TBL] [Abstract][Full Text] [Related]
9. Growth factor gene expression in kidney of murine polycystic kidney disease. Nakamura T; Ebihara I; Nagaoka I; Tomino Y; Nagao S; Takahashi H; Koide H J Am Soc Nephrol; 1993 Jan; 3(7):1378-86. PubMed ID: 8094982 [TBL] [Abstract][Full Text] [Related]
10. Diet and disease alter phosphoinositide composition and metabolism in murine polycystic kidneys. Aukema HM; Yamaguchi T; Tomobe K; Philbrick DJ; Chapkin RS; Takahashi H; Holub BJ J Nutr; 1995 May; 125(5):1183-91. PubMed ID: 7738678 [TBL] [Abstract][Full Text] [Related]
11. Sodium pump distribution is not reversed in the DBA/2FG-pcy, polycystic kidney disease model mouse. Kawa G; Nagao S; Yamamoto A; Omori K; Komatz Y; Takahashi H; Tashiro Y J Am Soc Nephrol; 1994 Jun; 4(12):2040-9. PubMed ID: 7919157 [TBL] [Abstract][Full Text] [Related]
12. Renal anemia in polycystic kidney disease mouse. Masunaga H; Hirabayashi M; Takahira R; Imai E; Kawanishi G J Vet Med Sci; 1991 Aug; 53(4):621-7. PubMed ID: 1834204 [TBL] [Abstract][Full Text] [Related]
13. Exploring urinary biomarkers in autosomal dominant polycystic kidney disease. Kawano H; Muto S; Ohmoto Y; Iwata F; Fujiki H; Mori T; Yan L; Horie S Clin Exp Nephrol; 2015 Oct; 19(5):968-73. PubMed ID: 25543187 [TBL] [Abstract][Full Text] [Related]
14. Specific changes in the basement membrane of the proximal tubules in the murine polycystic kidney detected by the novel anti-basement membrane monoclonal antibody D28. Nagao S; Koyama Y; Takahashi H Jikken Dobutsu; 1994 Oct; 43(4):511-9. PubMed ID: 7528684 [TBL] [Abstract][Full Text] [Related]
15. Effects of dietary supplementation with n-3 fatty acids on kidney morphology and the fatty acid composition of phospholipids and triglycerides from mice with polycystic kidney disease. Yamaguchi T; Valli VE; Philbrick D; Holub B; Yoshida K; Takahashi H Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):335-51. PubMed ID: 2236900 [TBL] [Abstract][Full Text] [Related]
16. Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study. Ogbron MR; Sareen S; Prychitko J; Buist R; Peeling J Am J Physiol; 1997 Jan; 272(1 Pt 2):F63-9. PubMed ID: 9039050 [TBL] [Abstract][Full Text] [Related]
17. Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice. Woo DD; Nguyen DK; Khatibi N; Olsen P J Clin Invest; 1997 Oct; 100(8):1934-40. PubMed ID: 9329956 [TBL] [Abstract][Full Text] [Related]
18. Tolvaptan delays the onset of end-stage renal disease in a polycystic kidney disease model by suppressing increases in kidney volume and renal injury. Aihara M; Fujiki H; Mizuguchi H; Hattori K; Ohmoto K; Ishikawa M; Nagano K; Yamamura Y J Pharmacol Exp Ther; 2014 May; 349(2):258-67. PubMed ID: 24570071 [TBL] [Abstract][Full Text] [Related]
19. Tracking kidney volume in mice with polycystic kidney disease by magnetic resonance imaging. Wallace DP; Hou YP; Huang ZL; Nivens E; Savinkova L; Yamaguchi T; Bilgen M Kidney Int; 2008 Mar; 73(6):778-81. PubMed ID: 18185504 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of NADPH Oxidase 2 Contributes to Renal Fibrosis in pcy Mice: An Experimental Model of Nephronophthisis. Hoshino Y; Sonoda H; Mikoda N; Ikeda M Nephron; 2022; 146(4):393-403. PubMed ID: 34942618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]